dm+d

Unassigned

New Medicines

Moderate to severe chronic obstructive pulmonary disease (COPD) in adults

Information

New molecular entity
Chiesi
Chiesi

Development and Regulatory status

None
Phase III Clinical Trials
None

Category

Phosphodiesterase 4 inhibitor
An estimated 1.2 million people are affected by COPD in the UK. There are 115,000 new diagnoses a year. Nevertheless, COPD remains underdiagnosed. 60-85% of patients, mainly with mild-to-moderate disease, are thought to remain undiagnosed [1].
Moderate to severe chronic obstructive pulmonary disease (COPD) in adults
Inhalation